Market · GlobeNewswire Inc. The induced pluripotent stem cell (iPSC) market is experiencing robust growth, with a projected ...
PALO ALTO, Calif., Jan. 30, 2026 /PRNewswire/ -- Leading GMP cell therapy CDMO I Peace, Inc. (https://ipeace.com/en/), specializing in induced pluripotent stem cells ...
Japanese researchers have made progress in the treatment of spinal cord injuries, offering hope to the approximately 20 million people worldwide affected by paralysis. On March 21, scientists from ...
Induced pluripotent stem cells (iPS cells) can be created from any tissue in the human body and possess the ability to transform into a wide range of tissues. Kobe University MARUYAMA Tatsuo and his ...
DUBLIN--(BUSINESS WIRE)--The "Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, & Forecasts, 2025" report has been added to ResearchAndMarkets.com's offering. Since the ...
Mayo Clinic's Translational Neuromuscular Disease Research Lab led by Nathan P. Staff, M.D., Ph.D., studies the biological ...
Tokyo-based K Pharma Inc. and Nikon Cell Innovation Co. on Tuesday signed a basic agreement on a new clinical trial project using induced pluripotent stem (iPS) cells to treat spinal cord injuries.
TOKYO & MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--BrightPath Bio (Tokyo Stock Exchange Growth 4594, “BrightPath”), a pioneer in iPS cell-derived Natural Killer T (“NKT”) cell therapy, and ...
The Allen Institute for Cell Science has released the Allen Cell Collection: the first publicly available collection of gene edited, fluorescently tagged human induced pluripotent stem cells that ...
Add Yahoo as a preferred source to see more of our stories on Google. TOKYO, Feb 19 (Reuters) - Japan's health ministry said on Thursday a panel of specialists had endorsed Sumitomo Pharma's iPS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results